España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AXONICS INC COM
AXNX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$70.98
At close: Nov 14, 4:46 PM EDT
$70.95
-0.03
-0.04%
After Hours: Nov 14, 4:46 PM EDT
Get Report
Comment
AXONICS INC COM (AXNX) Forecast
News
Earnings
AXONICS INC COM (AXNX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AXONICS INC COM (NASDAQ:AXNX) Stock
AXONICS INC COM Stock (NASDAQ: AXNX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 08, 2024
Needham Reiterates Hold on Axonics
Benzinga Newsdesk
Thursday, November 07, 2024
Axonics Q3 Sales $116.20M Beat $113.50M Estim...
Benzinga Newsdesk
Friday, September 27, 2024
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
Zacks
Thursday, September 26, 2024
Australia Therapeutic Goods Administration Ha...
Benzinga Newsdesk
Thursday, September 19, 2024
Reported Earlier, Axonics Prevails In Patent ...
Benzinga Newsdesk
Monday, August 05, 2024
Needham Reiterates Hold on Axonics
Benzinga Newsdesk
Thursday, May 16, 2024
Axonics Receives Approval From The Therapeuti...
Benzinga Newsdesk
Monday, May 06, 2024
Needham Reiterates Hold on Axonics
Benzinga Newsdesk
Tuesday, April 30, 2024
Axonics Q1 EPS $(0.38) Misses $(0.08) Estimat...
Benzinga Newsdesk
Thursday, April 18, 2024
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Vandana Singh
Thursday, April 04, 2024
Axonics shares are trading lower after the co...
Benzinga Newsdesk
Boston Scientific Earlier Disclosed That On A...
Benzinga Newsdesk
Friday, March 22, 2024
Axonics Stockholders Approve Merger Agreement...
Benzinga Newsdesk
Thursday, March 21, 2024
Axonics Updates On Inter Partes Review Procee...
Benzinga Newsdesk
Thursday, March 14, 2024
Axonics Announced That The Axonics R20 Rechar...
Benzinga Newsdesk
Thursday, February 29, 2024
Axonics Responds To ITC Action By Medtronic; ...
Benzinga Newsdesk
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
Benzinga Insights
RBC Capital Reiterates Sector Perform on Axon...
Benzinga Newsdesk
Wednesday, February 28, 2024
Axonics Q4 EPS $0.13 Beats $0.06 Estimate, Sales $109.73M Beat $107.33M Estimate
Happy Mohamed
Wednesday, January 31, 2024
Why Medical Devices Giant Boston Scientific Shares Are Rising Today
Nabaparna Bhattacharya
Wednesday, January 17, 2024
Needham Downgrades Axonics to Hold
Benzinga Newsdesk
Tuesday, January 16, 2024
Truist Securities Downgrades Axonics to Hold,...
Benzinga Newsdesk
Friday, January 12, 2024
Truist Securities Downgrades Axonics to Hold,...
Benzinga Newsdesk
CL King Downgrades Axonics to Neutral
Benzinga Newsdesk
Piper Sandler Downgrades Axonics to Neutral, ...
Benzinga Newsdesk
Leerink Partners Downgrades Axonics to Market...
Benzinga Newsdesk
Thursday, January 11, 2024
Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are Selling
Avi Kapoor
Wednesday, January 10, 2024
Wells Fargo Downgrades Axonics to Equal-Weigh...
Benzinga Newsdesk
Tuesday, January 09, 2024
Analyst Scoreboard: 5 Ratings For Axonics
Benzinga Insights
Wolfe Research Downgrades Axonics to Peer Per...
Benzinga Newsdesk
Monday, January 08, 2024
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Why Is Bladder Disorder Focused Axonics Stock Trading Higher Today?
Vandana Singh
Health Care Company Boston Scientific Announces Acquisition of Axonics
Benzinga Insights
Axonics shares are trading higher after the c...
Luke J Jacobi
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Axonics Expects FY23 Revenues Of Approximatel...
Benzinga Newsdesk
Axonics Expects Q4 FY23 Revenues Of $109.3M-$...
Benzinga Newsdesk
Axonics Has Entered Into A Definitive Agreeme...
Benzinga Newsdesk
Friday, December 22, 2023
Peeling Back The Layers: Exploring Axonics Through Analyst Insights
Benzinga Insights
Truist Securities Maintains Buy on Axonics, R...
Benzinga Newsdesk
Tuesday, October 31, 2023
Piper Sandler Maintains Overweight on Axonics...
Benzinga Newsdesk
Morgan Stanley Maintains Overweight on Axonic...
Benzinga Newsdesk
Needham Maintains Buy on Axonics, Lowers Pric...
Benzinga Newsdesk
Monday, October 30, 2023
Axonics Q3 2003 EPS $0.08 Beats $(0.05) Estim...
Benzinga Newsdesk
Earnings Scheduled For October 30, 2023
Benzinga Insights
Friday, October 27, 2023
Earnings Outlook For Axonics
Benzinga Insights
Monday, October 16, 2023
Leerink Partners Initiates Coverage On Axonic...
Benzinga Newsdesk
Monday, August 21, 2023
Axonics Appoints Kari Keese As CFO
Benzinga Newsdesk
Friday, July 28, 2023
Analyst Ratings for Axonics
Benzinga Insights
Axonics shares are trading higher after the c...
Benzinga Newsdesk
Show More